Marshall Wace’s Prelude Therapeutics PRLD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $33.8K | Buy |
+41,747
| New | +$33.8K | ﹤0.01% | 2470 |
|
|
2025
Q1 | – | Sell |
-392,155
| Closed | -$498K | – | 2823 |
|
|
2024
Q4 | $498K | Buy |
392,155
+33,018
| +9% | +$41.9K | ﹤0.01% | 1890 |
|
|
2024
Q3 | $743K | Buy |
+359,137
| New | +$743K | ﹤0.01% | 1638 |
|
|
2022
Q3 | – | Sell |
-45,716
| Closed | -$238K | – | 2965 |
|
|
2022
Q2 | $238K | Sell |
45,716
-66,061
| -59% | -$344K | ﹤0.01% | 2408 |
|
|
2022
Q1 | $772K | Sell |
111,777
-156,241
| -58% | -$1.08M | ﹤0.01% | 1938 |
|
|
2021
Q4 | $3.34M | Buy |
+268,018
| New | +$3.34M | 0.01% | 1406 |
|
|
2021
Q2 | – | Sell |
-29,315
| Closed | -$1.27M | – | 2449 |
|
|
2021
Q1 | $1.27M | Buy |
+29,315
| New | +$1.27M | 0.01% | 1302 |
|